Nomenclature for boranes and related species (IUPAC Recommendations 2019)
04 September 2020

The most recent IUPAC recommendations concerning boron hydrides and related compounds appeared in 2005. These recommendations reinforced earlier IUPAC recommendations in the subject area that had been published in 1990, but was essentially a ‘holding’ chapter, leaving new recommendations for a subsequent edition.

The Introduction to the 1990 recommendations held that the area of boron nomenclature is ‘contentious’ and ‘specialized’ and that the relevant Chapter (I-11) “is presented as a survey of nomenclature of simpler boron systems because boranes are much discussed even at relatively elementary levels of chemistry, and because we wish to codify those basic principles which seem firmly established”. Many of these recommendations were based on a Technical Report prepared in 1972 by R. Adams. This 1972 report expanded on a brief chapter on the nomenclature of boron compounds in the 1970 recommendations.

The purpose of this present document is to examine existing nomenclature recommendations to ensure that they can be clearly interpreted and to introduce new recommendations, incorporating new developments that have occurred in chemistry since these earlier reports. Each section is organized with numbered Recommendations followed by a more detailed commentary with relevant examples. Substituted boron-hydride cages are named here by a nomenclature that encompasses features borrowed from both ‘substitutive’ and ‘additive’ IUPAC nomenclature systems.

Nomenclature for boranes and related species (IUPAC Recommendations 2019)
Michael A. Beckett, Bernd Brellochs , Igor T. Chizhevsky , Ture Damhus , Karl-Heinz Hellwich , John D. Kennedy , Risto Laitinen , Warren H. Powell , Daniel Rabinovich , Clara Viñas and Andrey Yerin. 
Pure and Applied Chemistry, 92, 2, 2020
DOI: 10.1515/pac-2018-0205

Nomenclature for boranes and related species (IUPAC Recommendations 2019)

Hits: 579
Bioactive materials for therapy and diagnosis

Nomenclature for boranes and related species (IUPAC Recommendations 2019)

Also at ICMAB

  • Recombinant Human Epidermal Growth Factor/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing

    22 June 2021 49 hit(s) Biomaterials
    A multitude of microparticles and nanoparticles is developed to improve the delivery of different small drugs and large biomolecules, which are subject to several hindering biological barriers that limit their optimal biodistribution and therapeutic effects. Here, a soft, reliable, and scalable method based on compressed CO2 is reported for obtaining nanoconjugates of recombinant human epidermal growth factor and nanovesicles called quatsomes, where the latter consists of cholesterol and cetyltrimethylammonium bromide.These nanoconjugates exhibit appropriate values of the major critical quality attributes of colloidal nanomedicines, such as controlled and narrow nanoscopic particle size distribution (which play important roles in determining their stability), drug loading, drug release, drug protection, targeting ability, and bioactivity.
  • In vivo soft tissue reinforcement with bacterial nanocellulose

    11 May 2021 293 hit(s) Biomaterials
    The use of surgical meshes to reinforce damaged internal soft tissues has been instrumental for successful hernia surgery; a highly prevalent condition affecting yearly more than 20 million patients worldwide. Intraperitoneal adhesions between meshes and viscera are one of the most threatening complications, often implying reoperation or side effects such as chronic pain and bowel perforation.
  • Limbal Stem Cells on Bacterial Nanocellulose Carriers for Ocular Surface Regeneration

    13 April 2021 405 hit(s) Biomaterials
    Limbal stem cells (LSCs) are already used in cell‐based treatments for ocular surface disorders. Clinical translation of LSCs‐based therapies critically depends on the successful delivery, survival, and retention of these therapeutic cells to the desired region. Such a major bottleneck could be overcome by using an appropriate carrier to provide anchoring sites and structural support to LSC culture and transplantation.
  • Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment

    02 April 2021 436 hit(s) Biomaterials
    Fabry disease is a rare lysosomal storage disorder characterized by a deficiency of α-galactosidase A (GLA), a lysosomal hydrolase. The enzyme replacement therapy administering naked GLA shows several drawbacks including poor biodistribution, limited efficacy, and relatively high immunogenicity in Fabry patients.An attractive strategy to overcome these problems is the use of nanocarriers for encapsulating the enzyme. Nanoliposomes functionalized with RGD peptide have already emerged as a good platform to protect and deliver GLA to endothelial cells.
  • Radiolabeled Cobaltabis(dicarbollide) Anion–Graphene Oxide Nanocomposites for In Vivo Bioimaging and Boron Delivery

    23 March 2021 430 hit(s) Biomaterials
    A carbon-based hybrid nanocomposite, which consists of monoiodinated boron-cluster derivatives covalently attached to graphene oxide, is hereby introduced. This GO-I-COSAN has been synthesized using a novel boron-rich cobaltabis(dicarbollide) precursor with one iodide group attached to one of the boron atoms of the cluster (I-COSAN) and designed to be subsequently labeled with radioactive 124I for its use in positron emission tomography (PET).

INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA, Copyright © 2020 ICMAB-CSIC | Privacy Policy | This email address is being protected from spambots. You need JavaScript enabled to view it.